Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04520984 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Randomized-controlled Trial of Integrated Palliative and Nephrology Care Versus Usual Nephrology Care.
A Early Phase 1 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 45
- Enrollment target
NCT04520984 is a Early Phase 1 study that has completed, run by NYU Langone Health. The registered enrollment target is 45 participants.
The verdict
NCT04520984, a Early Phase 1 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The objective of this application is to conduct a pilot study testing the impact of integrated nephrology and palliative care versus standard nephrology care on patient-reported outcomes. This study is a preliminary study designed to determine feasibility of a palliative care study inclusive of kidney disease patients and to look for trends in impact over a 12-week follow-up period. Measurements will be taken at time one (time of enrollment) and time two (12 weeks). Our central hypothesis is that integration of palliative care with standard nephrology care in the ambulatory care of patients with a glomerular filtration rate (eGFR) ≤15ml/min/1.73m2 will trend towards improved symptom control, quality of life, and increased documentation of advance care planning when compared to usual nephrology care. We expect 10-15 patients per arm.
Interventions
- OTHER Integrated ambulatory palliative and nephrology care
- OTHER Standard nephrology care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-07-12 |
| Est. Completion | 2021-04-26 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04520984
The ClinicalTrials.gov registry entry for NCT04520984 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Integrated ambulatory palliative and nephrology care is the first listed.
NCT04520984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04520984 about?
NCT04520984 is a clinical study titled "Pilot Randomized-controlled Trial of Integrated Palliative and Nephrology Care Versus Usual Nephrology Care.". The objective of this application is to conduct a pilot study testing the impact of integrated nephrology and palliative care versus standard nephrology care on patient-reported outcomes. This study is a preliminary study designed to determine feasibility of a palliative care study inclusive of kidn...
What is the current status of trial NCT04520984?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2020-07-12. Estimated completion is 2021-04-26.
What interventions are being tested in trial NCT04520984?
The interventions under investigation include: Integrated ambulatory palliative and nephrology care (OTHER), Standard nephrology care (OTHER).
Who is sponsoring clinical trial NCT04520984?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.